Director, Centre for Regenerative Medicine and Stem Cell Research (Pakistan) April 5, 2026 | Canada Aga Khan University is recruiting a Director, Centre for Regenerative Medicine and Stem Cell Research based in Pakistan. The successful candidate will work in domains of regenerative and genomic medicine that align with regional priorities for South Asia and East Africa, including Mendelian and complex disorders. The high rates of consanguinity in Pakistan enables the discovery of novel pathogenic variants for Mendelian diseases. The Centre/AKU facilities enable the development of iPSC and animal models targeting patient‑specific variants, precise gene editing, investigation of signaling pathways, and drug testing. Together, these activities provide functional validation of disease‑causing variants and mechanisms and enable therapeutic development. Conditions with regional significance include blood disorders (sickle cell anaemia / thalassemia), neurodevelopmental disorders, metabolic disorders, cancers, and retinal disorders. The ideal candidate will have experience in bench‑to‑bedside translation of cell or gene therapies in these regionally relevant domains. To learn more or submit an application, please see the job posting. Thursday, April 30. About the Agency Chartered in 1983, Aga Khan University (AKU) is a private, autonomous and self‑governing international university, with 13 teaching sites in 6 countries over three continents. An integral part of the Aga Khan Development Network, AKU provides higher education in multiple health science and social science disciplines, carries out research pertinent primarily to low‑ and middle‑income countries and operates 7 hospitals (soon 8) and over 325 outreach clinics, all at international standards. It has almost 2,500 students and 14,000 staff. The University is both a model of academic excellence and an agent of social change. As a leading international institution dedicated to excellence and change, AKU operates on the core principles of quality, relevance, impact and access. #J-18808-Ljbffr